Table 5.

Linear regression analysis with follow-up FLAIR infarct volume as the outcome.

Variables	Unstandardized Coefficients		Multivariable Regression Model
	Unadjusted Beta	Standard Error	Adjusted Beta	Lower Bound	Upper Bound	p Value
rCBV < 42%	1.48	0.18	0.60	1.133	1.83	<0.001
Age	−0.56	0.40	−0.10	−1.36	0.23	0.16
Sex	−4.33	10.56	−0.03	−25.27	16.61	0.68
Race	3.78	7.74	0.03	−11.58	19.13	0.63
Hypertension	18.14	14.21	0.09	−10.06	46.34	0.21
Hyperlipidemia	−11.68	10.75	−0.07	−33.01	9.65	0.28
Diabetes Mellitus	28.39	12.27	0.16	4.04	52.73	<0.05
Heart Disease	0.67	12.08	0.004	−23.29	24.63	0.96
Atrial Fibrillation	5.17	12.24	0.03	−19.12	29.46	0.67
Occlusion Segment	−0.81	3.56	−0.02	−7.87	6.26	0.82
Prior transient Ischemic Attack or stroke	7.58	14.62	0.04	−21.43	36.58	0.61
Intravenous tissue-type plasminogen activator (IV tPA)	−22.00	11.69	−0.13	−45.15	1.14	0.06
Admission NIH Stroke Scale	0.89	0.83	0.08	−0.76	2.55	0.29
Premorbid Modified Rankin Score (mRS)	−0.48	5.29	−0.007	−10.98	10.02	0.93
Alberta Stroke Program Early CT Score (ASPECTS)	−9.37	2.99	−0.21	−15.29	−3.44	<0.01
The modified treatment in cerebral infarction (mTICI) score	−14.58	3.40	−0.28	−21.33	−7.825	<0.001